ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arizona » Nephrology

Top Nephrology Prescribers in Arizona

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID BEN ASHER MD

Nephrology

8,838

$529K

379
285 are 65+

17%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $100

MINDY JAN MD

Nephrology

7,841

$429K

705
561 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $100

TEH-LI HUO MD

Nephrology

7,767

$594K

626
463 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $100

ALEJANDRO RIVERO M.D.

Nephrology

7,665

$547K

345
228 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $100

KAMAL ELDIN AHMED M.D.

Nephrology

6,239

$902K

483
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 24%

$145
Average prescription price

Avg: $100

VIJAYAVEL PALANICHAMY MD

Nephrology

5,954

$328K

304
202 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $100

RICHARD FLICK M.D.

Nephrology

5,207

$688K

473
339 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 24%

$132
Average prescription price

Avg: $100

PAUL LUI MD

Nephrology

5,028

$872K

500
353 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$173
Average prescription price

Avg: $100

MOHAMMED SIKDER M.D.

Nephrology

4,896

$274K

434
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $100

SUSANA MYUNG M.D.

Nephrology

4,591

$328K

400
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $100

WILLIAM WEISS MD, PC

Nephrology

4,565

$225K

465
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $100

TRINIDAD LIM M.D.

Nephrology

4,384

$455K

436
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 24%

$104
Average prescription price

Avg: $100

PAUL WALSHAW M.D.

Nephrology

4,188

$307K

416
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $100

EDGUARDO LAUREL M.D.

Nephrology

4,068

$215K

259
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $100

DAVID WHITTMAN M.D., M.P.H.

Nephrology

4,066

$448K

288
176 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$110
Average prescription price

Avg: $100

SAVAS PETRIDES M.D.

Nephrology

4,044

$418K

292
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$103
Average prescription price

Avg: $100

ROMANITA NICA MD

Nephrology

4,018

$304K

455
352 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $100

ALEJANDRO MORALES M.D.

Nephrology

3,974

$503K

465
340 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 24%

$127
Average prescription price

Avg: $100

PURBA BISWAS MD

Nephrology

3,777

$316K

368
285 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$84
Average prescription price

Avg: $100

FREDRICK OSORIO M.D.

Nephrology

3,637

$177K

446
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $100

IRFAN FAZIL M.D.

Nephrology

3,483

$335K

455
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$96
Average prescription price

Avg: $100

VIJAY KUMAR M.D.

Nephrology

3,466

$297K

432
330 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $100

BINDU JAYAVELU M.D.

Nephrology

3,357

$225K

383
307 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $100

VALENTIN ZAHARIA M.D.

Nephrology

3,135

$273K

231
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$87
Average prescription price

Avg: $100

JEAN ROBEY M.D.

Nephrology

3,131

$335K

354
309 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$107
Average prescription price

Avg: $100

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank